National Institutes of Health logo
NIH Research Project Cooperative Agreement (U01)

NIDA Animal Genomics Program

Funds genomic work in animals on what makes addiction start, escalate, persist and relapse — any kind of genetic variant.

The National Institute on Drug Abuse funds this to find the genetic, genomic and epigenetic variants underneath addiction, using animal models.

Three things count as in scope. Phenotypes tied to addictive behaviour or to vulnerability at a particular stage of the substance use disorder trajectory — first use, escalation, tolerance, dependence, loss of control, abstinence, relapse, recovery. Behav

Genetic, genomic and epigenetic variants underlying addiction phenotypes in animal models — stages of the substance use disorder trajectory, associated behaviours such as impulsivity and novelty seeking, and genetically correlated comorbidities. Any variant type, with multi-omics, gene network and functional approaches encouraged.

CycleiHow often this grant runs — e.g. annually, on a rolling basis, or a one-off call.Multiple per year
Next deadlineiThe next date applications are due. Rolling means you can apply any time.11 Feb 2027
Decision timeiTypical time from the deadline to the funder's decision.26 weeks
Project durationiHow long the funded work is expected to run.
Award typeiThe form of funding — grant, equity, loan, tax credit, etc.Cooperative agreement
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.
Funding pooliThe total budget available across all awards in this round.

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see what you submit

Sign up free to see how they score you

Sign up free to see the timeline

Sign up free to see where teams trip up

Last verified: 25 Aug 2026Funder reference: PAR-24-269Source: www.grants.gov